Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: The importance of a learning curve

Cancer Journal

Volumn 15, Issue 3, 2009, Pages 196-199

  Mohamed, Faheez ^a   Moran, Brendan J ^a  

^a BASINGSTOKE AND NORTH HAMPSHIRE HOSPITAL   (United Kingdom)

Author keywords

Cytoreductive surgery; Hyperthermic intraperitoneal chemotherapy; Learning curve; Morbidity and mortality; Peritoneal carcinomatosis

Indexed keywords

CISPLATIN; FLUOROURACIL; IRINOTECAN; MITOMYCIN C; OXALIPLATIN; ANTINEOPLASTIC AGENT;

ABSCESS; ACUTE KIDNEY FAILURE; ANASTOMOSIS LEAKAGE; BILE LEAKAGE; BLOOD TOXICITY; BONE MARROW SUPPRESSION; BONE MARROW TOXICITY; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CARCINOMATOUS PERITONITIS; CARDIOVASCULAR DISEASE; CYTOREDUCTIVE SURGERY; DIALYSIS; FISTULA; GASTROINTESTINAL DISEASE; HEMATOMA; HEMOSTASIS; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; INFECTION; INTESTINE PERFORATION; LAPAROTOMY; LEARNING; LUNG DISEASE; LUNG EMBOLISM; MEDICAL EDUCATION; MORBIDITY; MULTIPLE ORGAN FAILURE; NEUTROPENIA; PANCREAS DISEASE; PATIENT SELECTION; PERIOPERATIVE COMPLICATION; PERITONEUM CANCER; PERITONEUM MESOTHELIOMA; PERITONEUM PSEUDOMYXOMA; PERITONITIS; PEROPERATIVE COMPLICATION; PLEURA EFFUSION; PNEUMOTHORAX; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; REOPERATION; REVIEW; SEPSIS; SEPTIC SHOCK; SMALL INTESTINE OBSTRUCTION; STANDARD; THORACOTOMY; TREATMENT OUTCOME; URINARY TRACT DISEASE; WOUND CLOSURE; HEALTH; HYPERTHERMIC THERAPY; INFUSION; MORTALITY; PERITONEUM TUMOR; REGIONAL PERFUSION; SURVIVAL RATE;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; MORBIDITY; PERITONEAL NEOPLASMS; SURVIVAL RATE; WORLD HEALTH;

EID: 67651163521     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0b013e3181a58d56     Document Type: Review

References (35)

1. World Health Organisation: Safe Surgery Saves Lives 2008. Available at: www.who.int/patientsafety/safesurgery/en/.
2. Haynes AB, Weiser TG, Berry WR, et al. A surgical safety checklist to reduce morbidity and mortality in a global population. N Engl J Med. 2009;360:491-499.
3. Nizard RS, Porcher R, Ravaud P, et al. Use of the Cusum technique for evaluation of a CT-based navigation system for total knee replacement. Clin Orthop Relat Res. 2004:180-188. (Pubitemid 39062768)
4. Dagash H, Chowdhury M, Pierro A. When can I be proficient in laparoscopic surgery? A systematic review of the evidence. J Pediatr Surg. 2003;38:720-724. (Pubitemid 36534800)
5. Roach PB, Silverstein JC. Training fellows and core competency: "making quality certain." J Surg Oncol. 2009;99:83-84.
6. Pellegrini CA, Warshaw AL, Debas HT. Residency training in surgery in the 21st century: a new paradigm. Surgery. 2004;136:953-965. (Pubitemid 39452293)
7. Sugarbaker PH. Clinical research to standard of care: when does the transition occur? Ann Surg Oncol. 2003;10:825-826.
8. Yan TD, Black D, Savady R, et al. A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol. 2007;14:484-492. (Pubitemid 46175292)
9. Koppe MJ, Boerman OC, Oyen WJ, et al. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg. 2006;243:212-222. (Pubitemid 43185440)
10. Younan R, Kusamura S, Baratti D, et al. Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy. J Surg Oncol. 2008;98:253-257.
11. Moran BJ, Mukherjee A, Sexton R. Operability and early outcome in 100 consecutive laparotomies for peritoneal malignancy. Br J Surg. 2006;93:100-104. (Pubitemid 43117313)
12. Murphy EM, Sexton R, Moran BJ. Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm. Dis Colon Rectum. 2007;50:37-42. (Pubitemid 46147019)
13. Butterworth SA, Panton ON, Klaassen DJ, et al. Morbidity and mortality associated with intraperitoneal chemotherapy for Pseudomyxoma peritonei. Am J Surg. 2002;183:529-532.
14. Smeenk RM, Verwaal VJ, Zoetmulder FA. Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei - a report of 103 procedures. Eur J Surg Oncol. 2006;32:186-190.
15. Loungnarath R, Causeret S, Bossard N, et al. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study. Dis Colon Rectum. 2005;48:1372-1379. (Pubitemid 40933864)
16. Glehen O, Osinsky D, Cotte E, et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol. 2003;10:863-869. (Pubitemid 40486849)
17. Sugarbaker PH, Ronnett BM, Archer A, et al. Pseudomyxoma peritonei syndrome. Adv Surg. 1996;30:233-280.
18. Moran BJ. Decision-making and technical factors account for the learning curve in complex surgery. J Public Health (Oxf). 2006;28:375-378.
19. Elias D, Honore C, Ciuchendea R, et al. Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Br J Surg. 2008;95:1164-1171.
20. Verwaal VJ, van Tinteren H, Ruth SV, et al. Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol. 2004;85:61-67. (Pubitemid 38160772)
21. Yan TD, Links M, Xu ZY, et al. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms. Br J Surg. 2006;93:1270-1276. (Pubitemid 44547028)
22. Witkamp AJ, de Bree E, Kaag MM, et al. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Br J Surg. 2001;88:458-463. (Pubitemid 32238713)
23. Jacquet P, Stephens AD, Averbach AM, et al. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer. 1996;77:2622-2629. (Pubitemid 26169161)
24. Stephens AD, Alderman R, Chang D, et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol. 1999;6:790-796. (Pubitemid 30013658)
25. Sugarbaker PH, Alderman R, Edwards G, et al. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Ann Surg Oncol. 2006;13:635-644.
26. Elias D, Laurent S, Antoun S, et al. [Pseudomyxoma peritonei treated with complete resection and immediate intraperitoneal chemotherapy]. Gastroenterol Clin Biol. 2003;27:407-412.
27. Cavaliere F, Valle M, De Rosa B, et al. [Peritonectomy and chemohyperthermia in the treatment of peritoneal carcinomatosis: learning curve]. Suppl Tumori. 2005;4:S119-S121.
28. Smeenk RM, Verwaal VJ, Zoetmulder FA. Learning curve of combined modality treatment in peritoneal surface disease. Br J Surg. 2007;94:1408-1414.
29. Yan TD, Links M, Fransi S, et al. Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy - a journey to becoming a Nationally Funded Peritonectomy Center. Ann Surg Oncol. 2007;14:2270-2280. (Pubitemid 47174916)
30. The Bristol Royal Infirmary Inquiry: Care in the Operating Theatre and the Learning Curve. Available at: www.bristol-inquiry.org.uk.
31. Guner Z, Schmidt U, Dahlke MH, et al. Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei. Int J Colorectal Dis. 2005;20:155-160. (Pubitemid 40227522)
32. Miner TJ, Shia J, Jaques DP, et al. Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg. 2005;241:300-308.
33. Stewart JH IV, Shen P, Russell GB, et al. Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. Ann Surg Oncol. 2006;13:624-634.
34. Smeenk RM, Verwaal VJ, Antonini N, et al. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg. 2007;245:104-109. (Pubitemid 46035441)
35. Baratti D, Kusamura S, Nonaka D, et al. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2008;15:526-534.